Global Antidiabetics Market Size will Exceed USD 80.0 Billion By - Erie News Now | WICU & WSEE in Erie, PA

Global Antidiabetics Market Size will Exceed USD 80.0 Billion By 2022


The global antidiabetics market size was US$ 41,305.7 million by 2013 and is projected to register a compound annual growth rate (CAGR) of more than 9.5% during the forecast period. The increasing number of diabetic patients, rising use of insulin, growing rates of obesity are expected to drive the antidiabetics market. However, stringent government regulations and loss of patent protection for antidiabetic drugs are expected to hamper the growth of the antidiabetics market.

In this report, the global antidiabetics market is segmented by type of insulin, product, and region. On the basis of type of insulin, the market is segmented into rapid-acting, long-acting, premixed, premixed analog, short-acting, and intermediate acting. The market on the basis of product is segmented into biguanides, thiazolodinediones, GLP-agonists, sulphonylureas, DPP-4 inhibitors, SGLT-2, alpha-glucosidase inhibitors, and meglitinides.

The global antidiabetics market is segmented on the basis of key regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America holds the largest share of the antidiabetics market. The region has the highest rate of obesity in the world which is one of the major reasons for the cause of diabetics. Furthermore, each region is segmented to provide market revenue for select countries such as the U.S., Canada, the U.K., Germany, China, Japan, India, Brazil, and GCC countries. The report includes a detailed study of the global and regional antidiabetics market and analyzes the variations in the growth of the industry in certain regions.

A glimpse of the report structure is provided in the report description available on the website.

Astra Zeneca Plc (U.K.), Boehringer Ingelheim GmbH (Germany), Eli Lilly & Co. (U.S.), Johnson & Johnson (U.S.), Mankind Pharma Ltd. (India), Merck & Co. Inc. (U.S.), Novartis AG (Switzerland), Novo Nordisk A/S (Denmark), Sanofi S.A. (France), and Teva Pharmaceutical Industries Ltd. (Israel) are the most active players in the antidiabetics market.

This report covers the antidiabetics market, in terms of value, and forecasts the market size till 2022. In addition, the report identifies key growth segments and opportunities in the industry. This report also covers detailed competitive outlook including the share and company profiles of the key players in the global antidiabetics market. Company profile includes company summary, financial summary, business strategy and planning, SWOT analysis, and current developments.

The deep-dive study on the antidiabetics market will help customers with the identification of new market opportunities and targeted promotional plans. The report provides global market trends, with data from 2013, estimates for 2014 and 2015, and projections of CAGRs through 2022.


Media Contact

Company Name: Market Research Engine

Contact Person: John Bay


Phone: +1-855-984-1862

Country: United States




Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact

Powered by Frankly
3514 State St. Erie, PA 16508
Newsroom: (814) 454-8812
Business offices: (814) 454-5201
Share Stories
Submit your stories to our site!
Share Photos
Share your photos in our community galleries
RSS Feeds
All content © Copyright 2000 - 2017 WICU. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.
                   WICU/WSEE - 3514 State Street Erie, PA 16508 - (814) 454-5201 -